MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $7,926,000 | -10.8% | 233,200 | -7.1% | 0.06% | -12.2% |
| Q1 2015 | $8,889,000 | +3.9% | 251,100 | 0.0% | 0.07% | +8.8% |
| Q4 2014 | $8,552,000 | -11.7% | 251,100 | 0.0% | 0.07% | -16.0% |
| Q3 2014 | $9,685,000 | -0.9% | 251,100 | 0.0% | 0.08% | +2.5% |
| Q2 2014 | $9,773,000 | +13.8% | 251,100 | 0.0% | 0.08% | +5.3% |
| Q1 2014 | $8,585,000 | +63.0% | 251,100 | 0.0% | 0.08% | +50.0% |
| Q4 2013 | $5,268,000 | +64.2% | 251,100 | +84.0% | 0.05% | +51.5% |
| Q3 2013 | $3,208,000 | – | 136,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |